Industry News
Cone snail proving to be companies' best friend
The cone snail, a marine snail from the Great Barrier Reef, is proving to be a vaulable ally in pain management drug research. [ + ]
MicroMedical's human heart trials imminent
Australia's first artificial hearts are to be implanted in human patients within weeks, according to the developer. [ + ]
Consolidation contributes to Agenix half-year profit
Agenix Limited (ASX: AGH) has announced a 435 per cent increase in after-tax profit to $1.7 million for the six months to December 31, 2001. [ + ]
Applications urged for $100m fund
Queensland researchers are being urged to take advantage of the state government's $100 million Smart State Research Facility Fund by getting their applications in before March 4.
[ + ]Autogen files new US patents
Australian genomics company Autogen has filed US patent applications for five new genes related to obesity and type 2 diabetes. [ + ]
New imaging company hits the capital-raising trail
Australia's latest biotech public share offering opened today as vision sciences company IATIA began efforts to raise $5 million. [ + ]
New IMB research targets cystic fybrosis
Queensland bioresearchers have discovered a promising method for treating a common bacterial infection afflicting cystic fibrosis patients. [ + ]
Go west, young biotech entrepreneur
BioWest, the first directory for the biotechnology industry in western Sydney, is being launched today by Kim Yeadon, NSW Minister for Western Sydney. [ + ]
No GM wheat here: Monsanto
The Australian branch of agricultural biotechnology giant Monsanto today refuted reports that its herbicide resistant genetically modified wheat seed was taking longer than expected to gain approval in the US. [ + ]
Heavyweight board a coup for start-up Farmacule
Queensland molecular farming start-up Farmacule Bioindustries has scored a mini-coup by appointing ex-Dow Chemical heavyweight Dr Paul Zorner to its board. [ + ]
Thrombogenix to change its name
Kinase and blood-clotting disease research group Thrombogenix is within weeks of a name change intended to reflect a broader focus. [ + ]
We'll float when we're ready, says PSL chief
Sydney-based company Proteome Systems Limited (PSL) has participated in a new round of capital raising as speculation mounts about the timing of the company's public float. [ + ]
'Poor performer' biotechs urge shareholders to take the long view
Two biotech companies, Biota Holdings and Progen Industries, have popped up on the Australian Shareholders Association's 2002 list of 'Poor Performers'. [ + ]
Genomic analysis software gets US launch
A new, Melbourne-developed microarray analysis software program is to be unveiled at a major genomics conference in the United States tomorrow. [ + ]
New biotech network aims for power in numbers
A new biotechnology network is aiming for a "power in numbers approach" to garner industry and government support for groups working in the industry. [ + ]
